Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

First results of the COVID-19 in MS Global Data Sharing Initiative suggest anti-CD20 DMTs are associated with worse COVID-19 outcomes

Research Alert

Newswise — Background: As the COVID-19 pandemic amplifies, efforts to minimise the risk on vulnerable people are essential. People with multiple sclerosis (MS) may be a vulnerable group due to the high proportion taking long-term immunosuppressive disease-modifying therapies (DMTs). Studies from Italy and France suggest older age, higher disability and progressive MS are associated with severe COVID-19, yet there remains uncertainty around the influence of DMTs.

Objectives: Given the many approved MS DMTs and the relatively low frequency of COVID-19 in MS patients per country, international data sharing is desirable to examine the impact of DMTs on COVID-19 severity. Here, we present the first results of the COVID-19 in MS global data sharing initiative of the MS International Federation and MS Data Alliance and many other data partners to inform MS clinical management during the COVID-19 pandemic.

Methods: Clinician-reported data from 21 countries were aggregated into a dataset of 1540 patients. Characteristics of admission to hospital, admission to intensive care unit (ICU), need for artificial ventilation, and death, were assessed in patients with confirmed or suspected COVID-19 infection using log-binomial regression. Adjusted prevalence ratios (aPR) were calculated adjusting for age, sex, MS type, and Expanded Disability Status Scale (EDSS).

Results: Of 1540 patients, 476 (30.9%) with suspected and 776 (50.4%) with confirmed COVID-19 were included in the analysis. Older age, progressive MS and higher EDSS were associated with higher frequencies of severe outcomes. Anti-CD20 DMTs, ocrelizumab and rituximab, were positively associated with hospital admission (aPRs=1.19 & 1.58), ICU admission (aPRs=3.53 & 4.12), and the need for artificial ventilation (aPRs=3.17 & 7.27) compared to dimethyl fumarate. Higher frequencies of all three outcomes were associated with combined anti-CD20 DMT use compared to all other DMTs (hospitalisation aPR=1.49; ICU aPR=2.55; ventilation aPR=3.05) and compared to natalizumab (hospitalisation aPR=1.99; ICU aPR=2.39; ventilation aPR=2.84). Importantly, associations persisted on restriction to confirmed COVID-19 cases and upon exclusion of each contributing data source in turn. No associations were observed between DMTs and death.

Conclusions: This study used the largest federated international cohort of people with MS and COVID19 currently available. We demonstrate a consistent association of anti-CD20 DMTs with hospitalisation, ICU admission and use of artificial ventilation suggesting their use among MS patients at risk for COVID-19 exposure may be a risk factor for more severe COVID-19 disease. To address study limitations, further research incorporating comorbidities, smoking and body mass index is required. Alternative study designs are needed to address questions on COVID-19 susceptibility among people with MS.

Presenter: Steve Simpson-Yap, The University of Melbourne, Melbourne School Of Population And Global Health




Filters close

Showing results

110 of 3733
Released: 21-Oct-2020 3:40 PM EDT
Pastoral care shown to support older people at risk from COVID-19
Staffordshire University

Volunteers from the Catholic Church in Brazil helped to mitigate the impact of COVID-19 among the elderly, a new study shows.

Newswise: UH Implements Virtual Waiting Room for Patients During COVID-19 Pandemic
Released: 21-Oct-2020 3:30 PM EDT
UH Implements Virtual Waiting Room for Patients During COVID-19 Pandemic
University Hospitals Cleveland Medical Center

UH has implemented PatientTrak, a virtual waiting room that enables the patient to communicate effectively with staff so they can arrive at their appointment on time while avoiding an in-person waiting room.

Released: 21-Oct-2020 3:15 PM EDT
Mass screening method could slash COVID-19 testing costs, trial finds
University of Edinburgh

Using a new mathematical approach to screen large groups for Covid-19 could be around 20 times cheaper than individual testing, a study suggests.

Newswise: 246543_web.jpg
Released: 21-Oct-2020 2:45 PM EDT
Observed COVID-19 variability may have underlying molecular sources
University of California, Riverside

People have different susceptibilities to SARS-CoV-2, the virus behind the COVID-19 pandemic, and develop varying degrees of fever, fatigue, and breathing problems -- common symptoms of the illness. What might explain this variation?

Released: 21-Oct-2020 2:10 PM EDT
Hospitals Leaned Toward Strict COVID-19 NICU Policies Despite Low Prevalence of Infection, New Study Finds
George Washington University

Two studies examining the impact of COVID-19 on neonatal intensive care units (NICUs) found the prevalence of COVID-19 in NICU infants is low, yet many hospitals at the start of the pandemic put in place strict parental visitation policies and scaled back NICU services such as lactation support and therapy.

Newswise: Tracking the SARS-CoV-2 Virus with Genome Sequencing
Released: 21-Oct-2020 2:05 PM EDT
Tracking the SARS-CoV-2 Virus with Genome Sequencing
University of North Carolina School of Medicine

Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing. Using next generation sequencing on SARS-CoV-2 will help accurately diagnose the novel coronavirus, identify mutations and track its history.

Released: 21-Oct-2020 12:55 PM EDT
Study assessing how early childhood educators spend time away from students
University of Nebraska-Lincoln

Much attention is paid to the work early childhood teachers do in the classroom, but their tasks away from their students can be just as essential to children’s learning and development.

Released: 21-Oct-2020 12:50 PM EDT
Rutgers Pediatricians Sound Alarm on Decreased Flu Vaccinations, Immunizations for Children
Rutgers University-New Brunswick

Two Rutgers New Jersey Medical School pediatricians discuss the importance of keeping children and adults up to date with immunizations during the coronavirus crisis.

Released: 21-Oct-2020 11:35 AM EDT
Trump's claim that House Speaker Nancy Pelosi is to blame for the stalled COVID-19 stimulus legislation is not accurate
Newswise

President Donald Trump has repeatedly blamed the U.S. House Speaker Nancy Pelosi for "not caring about Americans" since she would not agree to his terms for COVID-19 relief aid. We rate these claims as mostly false because they are misleading. According to the New York Times, Senator Mitch McConnell, Republican of Kentucky and the majority leader, told Republican senators privately on Tuesday that he has advised the White House not to strike a deal with Speaker Nancy Pelosi on a new stimulus bill before Election Day.


Showing results

110 of 3733

close
1.56417